Integrated structure-based activity prediction model of benzothiadiazines on various genotypes of HCV NS5b polymerase (1a, 1b and 4) and its application in the discovery of new derivatives (vol 20, pg 2455, 2012)

被引：0
|
作者：
Ismail, Mohamed A. H. [1 ]
Abou El Ella, Dalal A. [1 ]
Abouzid, Khaled A. M. [1 ]
Mahmoud, Amr H. [1 ]
机构：
[1] Ain Shams Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11566, Egypt
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2013年 / 21卷 / 17期
关键词：
D O I：
10.1016/j.bmc.2013.07.001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：5647 / 5647
页数：1
相关论文
共 13 条
  • [1] Integrated structure-based activity prediction model of benzothiadiazines on various genotypes of HCV NS5b polymerase (1a, 1b and 4) and its application in the discovery of new derivatives
    Ismail, Mohamed A. H.
    El Ella, Dalal A. Abou
    Abouzid, Khaled A. M.
    Mahmoud, Amr H.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (07) : 2455 - 2478
  • [2] Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus
    Paulson, Matthew S.
    Yang, Huiling
    Shih, I-hung
    Feng, Joy Y.
    Mabery, Eric M.
    Robinson, Margaret F.
    Zhong, Weidong
    Delaney, William E.
    ANTIVIRAL RESEARCH, 2009, 83 (02) : 135 - 142
  • [3] A highly selective structure-based virtual screening model of Palm I allosteric inhibitors of HCV Ns5b polymerase enzyme and its application in the discovery and optimization of new analogues
    Mahmoud, Amr H.
    Abou El Ella, Dalal A.
    Ismail, Mohamed A. H.
    Abouzid, Khaled A. M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 57 : 468 - 482
  • [4] SAFETY AND ANTIVIRAL ACTIVITY OF NS5B POLYMERASE INHIBITOR MK-3281, IN TREATMENT-NAiVE GENOTYPE 1A, 1B AND 3 HCV-INFECTED PATIENTS
    Brainard, Diana M.
    Anderson, Matt S.
    Petry, Amelia
    Van Dyck, Kristien
    De Lepeleire, Inge
    Sneddon, Kenneth
    Cummings, Corinne E.
    Nachbar, Robert B.
    Barnard, Richard J.
    Sun, Peng
    Panorchan, Paul
    Sanderson, Joseph B.
    Udezue, Emmanuel
    Wagner, Frank
    Iwamoto, Marian
    Chodakewitz, Jeffrey
    Wagner, John A.
    HEPATOLOGY, 2009, 50 (04) : 1026A - 1027A
  • [5] Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV) (vol 55, pg 7650, 2012)
    Beaulieu, Pierre L.
    Boes, Michael
    Cordingley, Michael G.
    Chabot, Catherine
    Fazal, Gulrez
    Garneau, Michel
    Gillard, James R.
    Jolicoeur, Eric
    LaPlante, Steven
    McKercher, Ginette
    Poirier, Martin
    Poupart, Marc-Andre
    Tsantrizos, Youla S.
    Duan, Jianmin
    Kukolj, George
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (16) : 7144 - 7144
  • [6] Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: Discovery of a quinazolinone chemotype
    Beaulieu, Pierre L.
    Coulombe, Rene
    Duan, Jianmin
    Fazal, Gulrez
    Godbout, Cedrickx
    Hucke, Oliver
    Jakalian, Araz
    Joly, Marc-Andre
    Lepage, Olivier
    Llinas-Brunet, Montse
    Naud, Julie
    Poirier, Martin
    Rioux, Nathalie
    Thavonekham, Bounkham
    Kukolj, George
    Stammers, Timothy A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (14) : 4132 - 4140
  • [7] Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 2: Non-symmetric inhibitors with potent activity against genotype 1a and 1b
    Giroux, Simon
    Bilimoria, Darius
    Cadilhac, Caroline
    Cottrell, Kevin M.
    Denis, Francois
    Dietrich, Evelyne
    Ewing, Nigel
    Henderson, James A.
    L'Heureux, Lucille
    Mani, Nagraj
    Morris, Mark
    Nicolas, Olivier
    Reddy, T. Jagadeeswar
    Selliah, Subajini
    Shawgo, Rebecca S.
    Xu, Jinwang
    Chauret, Nathalie
    Berlioz-Seux, Francoise
    Chan, Laval C.
    Das, Sanjoy K.
    Grillot, Anne-Laure
    Bennani, Youssef L.
    Maxwell, John P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (04) : 940 - 943
  • [8] Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase
    Kim, Sun Hee
    Tran, Martin T.
    Ruebsam, Frank
    Xiang, Alan X.
    Ayida, Benjamin
    McGuire, Helen
    Ellis, David
    Blazel, Julie
    Tran, Chinh V.
    Murphy, Douglas E.
    Webber, Stephen E.
    Zhou, Yuefen
    Shah, Amit M.
    Tsan, Mei
    Showalter, Richard E.
    Patel, Rupal
    Gobbi, Alberto
    LeBrun, Laurie A.
    Bartkowski, Darian M.
    Nolan, Thomas G.
    Norris, Daniel A.
    Sergeeva, Maria V.
    Kirkovsky, Leo
    Zhao, Qiang
    Han, Qing
    Kissinger, Charles R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4181 - 4185
  • [9] HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives
    Wang, Guangyi
    He, Yanzhen
    Sun, Jun
    Das, Debasis
    Hu, Mougang
    Huang, Jianhua
    Ruhrmund, Donald
    Hooi, Lisa
    Misialek, Shawn
    Rajagopalan, P. T. Ravi
    Stoycheva, Antitsa
    Buckman, Brad O.
    Kossen, Karl
    Seiwert, Scott D.
    Beigelman, Leonid
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4476 - 4479
  • [10] MEDI 239-Inhibitors of HCV NS5B polymerase: Synthesis and structure-activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthylene benzothiadiazine derivatives
    Krueger, A. Chris
    Madigan, Darold L.
    Bosse, Todd D.
    Jiang, Wen W.
    Kati, Warren M.
    Larson, Daniel P.
    Liu, Yaya
    Maring, Clarence J.
    Masse, Sherie
    Middleton, Tim
    Mo, Hongmei
    Molla, Akhteruzzaman
    Montgomery, Debra
    Kempf, Dale J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
12